Skin hyperreactivity response (pathergy) in Behçet's disease

Area of Science:

• Immunology
• Dermatology
• Rheumatology

Background:

• Behçet's disease diagnosis is challenging due to overlapping symptoms with other systemic conditions.
• There is a need for reliable non-clinical diagnostic criteria for Behçet's disease.
• Pathergy, a nonspecific cutaneous hyperreactivity, is a potential diagnostic indicator.

Purpose of the Study:

• To evaluate the diagnostic utility of pathergy in Behçet's disease.
• To investigate the role of immune complex mechanisms in Behçet's disease pathogenesis using pathergy testing.

Main Methods:

• Conducted a study involving 11 patients diagnosed with Behçet's disease.
• Performed histamine and saline injections to assess cutaneous hyperreactivity (pathergy).
• Analyzed clinical and histological responses at 4 and 24 hours post-injection, including immunoglobulin and complement deposition.

Main Results:

• No immunoglobulin or complement deposition was observed at 4 hours post-injection.
• 10 out of 11 active-stage Behçet's disease patients showed positive clinical and histological pathergy responses at 24 hours.
• Evidence of vasculitis was minimal (2 patients), suggesting limited immune complex involvement in most cases.

Conclusions:

• Nonspecific intracutaneous injections, demonstrating pathergy, are a valuable clinical tool for diagnosing Behçet's disease.
• The pathergy test can aid in diagnosing Behçet's disease, even in the absence of clear immune complex findings.